ARTICLE | Company News

Vaxine, GlaxoSmithKline, NIH infectious news

October 6, 2014 7:00 AM UTC

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded five-year contracts to Vaxine, GlaxoSmithKline's Corixa Corp. unit and five research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system. The agency said total funding for all seven contracts could reach $70 million. ...